SPYRE THERAPEUTICS, INC. Additional Paid in Capital
SPYRE THERAPEUTICS, INC. (SYRE) had Additional Paid in Capital of $250.30 million as of 2019-03-31, per its 10-Q filed 2019-05-07.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2019-05-07
- 2019-03-31: Additional Paid in Capital $250.30M.
- 2018-12-31: Additional Paid in Capital $184.31M.
- 2018-09-30: Additional Paid in Capital $165.68M.
- 2018-06-30: Additional Paid in Capital $163.55M.
| Period end | Additional Paid in Capital |
|---|---|
| 2019-03-31 | $250.30M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $184.31M 10-Q · filed 2019-05-07 |
| 2018-09-30 | $165.68M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $163.55M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $124.65M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $122.95M 10-K · filed 2019-03-07 |
| 2017-09-30 | $121.57M 10-Q · filed 2017-11-07 |
| 2017-06-30 | $120.79M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $108.74M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $108.25M 10-K · filed 2018-03-13 |
| 2016-09-30 | $107.99M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $107.48M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $1.51M 10-Q · filed 2016-05-19 |
| 2015-12-31 | $1.37M 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |